Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: Case reports of tuberculous lymphadenitis

Internal Medicine

Volumn 48, Issue 2, 2009, Pages 115-119

  Ataergin, Selmin ^a   Arslan, Nuri ^a   Ozet, Ahmet ^a   Ozguven, M Ali ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cancer; Positron emission tomography; Tuberculosis

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETHAMBUTOL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINATE CALCIUM; ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; TAMOXIFEN; TUBERCULOSTATIC AGENT; VINCRISTINE; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; BREAST CANCER; CANCER PATIENT; CANCER REGRESSION; CASE REPORT; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; LYMPH NODE BIOPSY; MULTIPLE CYCLE TREATMENT; MYCOBACTERIUM TUBERCULOSIS; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; STOMACH LYMPHOMA; TUBERCULOUS LYMPHADENITIS; BREAST TUMOR; COLON TUMOR; DIFFERENTIAL DIAGNOSIS; LIVER TUMOR; LYMPH NODE METASTASIS; LYMPHOMA; METASTASIS; MIDDLE AGED; NEOPLASM; SCINTISCANNING; STOMACH TUMOR; TUMOR RECURRENCE;

ANTITUBERCULAR AGENTS; BREAST NEOPLASMS; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STOMACH NEOPLASMS; TUBERCULOSIS, LYMPH NODE;

EID: 61749090163     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1536     Document Type: Article

References (22)

1. Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis 42: 1592-1595, 2006.
2. Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK. Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 23: 737-743, 1996.
3. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 23: 717-735, 1996.
4. Yasuda S, Ide M, Takagi S, Shohtsu A. Cancer screening with whole-body FDG PET. 33: 1065-1071, 1996 (in Japanese).
5. Knopp MV, Bischoff HG. Evaluation of pulmonary lesions with positron emission tomography. Radiologe 34: 588-591, 1994 (in German).
6. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 31: 1927-1932, 1990.
7. Hubner KF, Buonocore E, Singh SK, Gould HR, Cotten DW. Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med 20: 293-298, 1995.
8. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23: 1409-1415, 1996.
9. Alavi A, Gupta N, Alberini JL, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 32: 293-321, 2002.
10. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33: 1972-1980, 1992.
11. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 216: 117-121, 2000.
12. Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23: 315-340, 2003.
13. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 23: 739-742, 1998.
14. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 109: 982-988, 1996.
15. Patz EF Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188: 487-490, 1993.
16. Schmitz A, Kälicke T, Willkomm P, Grünwald F, Kandyba J, Schmitt O. Use of fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in assessing the process of tuberculous spondylitis. J Spinal Disord 13: 541-544, 2000.
17. Turkington TG, Coleman RE. Clinical oncologic positron emission tomography: an introduction. Semin Roentgenol 37: 102-109, 2002.
18. Hara T, Kosaka N, Suzuki T, Kudo K, Niino H. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest 124: 893-901, 2003.
19. Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 25: 1238-1243, 1998.
20. Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol 19: 161-164, 2000.
21. Bleeker-Rovers CP, Bredie SJ, van der, Meer JW, Corstens FH, Oyen WJ. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61: 323-329, 2003.
22. Ha HK, Jung JI, Lee MS, et al. CT differentiation of tuberculous peritonitis and peritoneal carcinomatosis. AJR Am J Roentgenol 167: 743-748, 1996.